DistantNews
Support us
To Antarctica for research: Scientist explains why antibiotics are losing their edge Image: archiv Stanislavy Bezdรญฤek Krรกlovรฉ
๐Ÿ‡จ๐Ÿ‡ฟ Czech Republic /Health & Science

To Antarctica for research: Scientist explains why antibiotics are losing their edge

From iDNES · () Czech

Translated from Czech and summarized by DistantNews. Read the original for the full story.

At a glance

In-depth Named sources Context piece
  • Antibiotic-resistant microorganisms contributed to five million deaths in 2019, according to Stanislava Bezdรญฤek Krรกlovรก.
  • Estimates cited in the article suggest that figure could double by 2050.
  • The article follows research connected with Antarctica and the growing challenge of antibiotic resistance.

Antibiotics have saved millions of lives. Now, their success is helping create a threat: bacteria are adapting to the drugs faster than scientists can develop replacements.

โ€œResistant microorganisms contributed to five million deaths in 2019. By 2050, that number is expected to double,โ€ says scientist Stanislava Bezdรญฤek Krรกlovรก.

The warning comes in the context of research linked to Antarctica. The article presents antibiotic resistance as a problem driven by the widespread use of medicines that once transformed the treatment of infections. As the drugs lose effectiveness, researchers face a race to find new therapies.

The article does not provide further details about the Antarctic research, but its central message is clear: medicines that once reliably fought bacterial infections are gradually becoming less dependable.

Resistant microorganisms contributed to five million deaths in 2019. By 2050, that number is expected to double.

โ€” Stanislava Bezdรญฤek KrรกlovรกThe scientist describes the current and projected death toll associated with antimicrobial resistance.
About this summary

Originally published by iDNES in Czech. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.